Alastair Aitken

11.4k total citations · 2 hit papers
120 papers, 9.2k citations indexed

About

Alastair Aitken is a scholar working on Molecular Biology, Cell Biology and Pharmacology. According to data from OpenAlex, Alastair Aitken has authored 120 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Molecular Biology, 19 papers in Cell Biology and 18 papers in Pharmacology. Recurrent topics in Alastair Aitken's work include 14-3-3 protein interactions (38 papers), Ubiquitin and proteasome pathways (24 papers) and Microbial Natural Products and Biosynthesis (15 papers). Alastair Aitken is often cited by papers focused on 14-3-3 protein interactions (38 papers), Ubiquitin and proteasome pathways (24 papers) and Microbial Natural Products and Biosynthesis (15 papers). Alastair Aitken collaborates with scholars based in United Kingdom, Tanzania and United States. Alastair Aitken's co-authors include Philip Cohen, Stephen J. Smerdon, S.J. Gamblin, Katrin Rittinger, Henrik Leffers, Lewis C. Cantley, Michael B. Yaffe, Stefano Volinia, Paul R. Caron and David H. Jones and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Alastair Aitken

118 papers receiving 8.9k citations

Hit Papers

The Structural Basis for 14-3-3:Phosphopeptide Binding Sp... 1997 2026 2006 2016 1997 2006 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alastair Aitken United Kingdom 45 8.2k 1.4k 1.1k 732 618 120 9.2k
Sherry Niessen United States 43 4.5k 0.6× 1.3k 0.9× 810 0.7× 621 0.8× 351 0.6× 78 6.8k
Tatsuya Tamaoki Japan 31 4.3k 0.5× 719 0.5× 714 0.6× 324 0.4× 695 1.1× 66 6.6k
Friedrich Marks Germany 49 4.7k 0.6× 1.1k 0.8× 1.5k 1.3× 237 0.3× 342 0.6× 222 8.1k
Kazuyoshi Yonezawa Japan 47 9.3k 1.1× 2.0k 1.5× 413 0.4× 354 0.5× 893 1.4× 97 11.9k
Thomas W. Sturgill United States 52 9.6k 1.2× 1.9k 1.4× 454 0.4× 418 0.6× 904 1.5× 101 11.7k
Flavio Meggio Italy 50 6.9k 0.8× 1.1k 0.8× 268 0.2× 887 1.2× 310 0.5× 141 8.7k
Robert J. Deschenes United States 38 4.9k 0.6× 1.8k 1.3× 227 0.2× 517 0.7× 839 1.4× 68 6.3k
Stephan Wullschleger Switzerland 21 6.3k 0.8× 950 0.7× 459 0.4× 482 0.7× 445 0.7× 26 8.8k
Robbie Loewith Switzerland 41 12.2k 1.5× 2.6k 1.9× 950 0.9× 1.3k 1.8× 618 1.0× 67 15.4k
Jozef Goris Belgium 44 5.9k 0.7× 1.8k 1.3× 239 0.2× 463 0.6× 575 0.9× 129 7.4k

Countries citing papers authored by Alastair Aitken

Since Specialization
Citations

This map shows the geographic impact of Alastair Aitken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alastair Aitken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alastair Aitken more than expected).

Fields of papers citing papers by Alastair Aitken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alastair Aitken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alastair Aitken. The network helps show where Alastair Aitken may publish in the future.

Co-authorship network of co-authors of Alastair Aitken

This figure shows the co-authorship network connecting the top 25 collaborators of Alastair Aitken. A scholar is included among the top collaborators of Alastair Aitken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alastair Aitken. Alastair Aitken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steinacker, Petra, Alastair Aitken, & Markus Otto. (2011). 14-3-3 proteins in neurodegeneration. Seminars in Cell and Developmental Biology. 22(7). 696–704. 78 indexed citations
2.
Stevenson, Ross, Helen C. Baxter, Alastair Aitken, Tom Brown, & Robert L. Baxter. (2008). Binding of 14-3-3 proteins to a single stranded oligodeoxynucleotide aptamer. Bioorganic Chemistry. 36(5). 215–219. 12 indexed citations
3.
Li, Zenggang, Jing Zhao, Yuhong Du, et al.. (2007). Down-regulation of 14-3-3ζ suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proceedings of the National Academy of Sciences. 105(1). 162–167. 128 indexed citations
4.
Paterson, Janet M., Duncan M. Short, Peter W. Flatman, et al.. (2006). Changes in protein expression in the rat medial vestibular nuclei during vestibular compensation. The Journal of Physiology. 575(3). 777–788. 26 indexed citations
5.
Clokie, Samuel, et al.. (2005). BCR kinase phosphorylates 14‐3‐3 Tau on residue 233. FEBS Journal. 272(15). 3767–3776. 23 indexed citations
6.
Chen, Hung-Kai, Pedro Fernández-Fúnez, Summer F. Acevedo, et al.. (2003). Interaction of Akt-Phosphorylated Ataxin-1 with 14-3-3 Mediates Neurodegeneration in Spinocerebellar Ataxia Type 1. Cell. 113(4). 457–468. 333 indexed citations
8.
Dubois, Thierry, et al.. (2003). Novel in vitro and in vivo phosphorylation sites on protein phosphatase 1 inhibitor CPI-17. Biochemical and Biophysical Research Communications. 302(2). 186–192. 18 indexed citations
10.
Aitken, Alastair. (1999). Protein Consensus Sequence Motifs. Molecular Biotechnology. 12(3). 241–254. 43 indexed citations
11.
Aitken, Alastair, et al.. (1998). Human Cruciform Binding Protein Belongs to the 14-3-3 Family. Biochemistry. 37(40). 14317–14325. 46 indexed citations
12.
Yaffe, Michael B., Katrin Rittinger, Stefano Volinia, et al.. (1997). The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity. Cell. 91(7). 961–971. 1378 indexed citations breakdown →
13.
Dubois, Thierry, Christian Rommel, Steven Howell, et al.. (1997). 14-3-3 Is Phosphorylated by Casein Kinase I on Residue 233. Journal of Biological Chemistry. 272(46). 28882–28888. 131 indexed citations
14.
Radziwill, Gerald, et al.. (1996). Inhibition of Raf/MAPK Signaling inXenopusOocyte Extracts by Raf-1-Specific Peptides. Biochemical and Biophysical Research Communications. 227(1). 20–26. 6 indexed citations
15.
Sharma, N.D., et al.. (1994). Evidence for the glycosylation of porcine serum transferrin at a single site located within the C-terminal lobe. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1206(2). 286–288. 11 indexed citations
17.
Aitken, Alastair. (1990). Identification of protein consensus sequences : active site motifs, phosphorylation, and other post-translational modifications. Ellis Horwood eBooks. 10 indexed citations
18.
Evans, A.T., et al.. (1989). The ability of diterpene esters with selective biological effects to activate protein kinase C and induce HL-60 cell differentiation. Biochemical Pharmacology. 38(17). 2925–2927. 2 indexed citations
19.
Brooks, Gavin, A.T. Evans, Alastair Aitken, & Fred J. Evans. (1987). Sapintoxin A. A fluorescent phorbol ester that is a potent activator of protein kinase C but is not a tumour promoter. Cancer Letters. 38(1-2). 165–170. 13 indexed citations
20.
Aitken, Alastair & Philip Cohen. (1984). [19] Identification of N-terminal myristyl blocking groups in proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 106. 205–210. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026